Abstract:ABSTRACT African swine fever virus (ASFV) is a large and complex DNA virus that causes a highly lethal swine disease, against which there is no vaccine available except in Vietnam. ASFV has developed multiple strategies to evade the antiviral innate immune responses. Here, we revealed that the D129L protein (pD129L), a nonstructural protein of ASFV, counteracted the type I interferon (IFN) responses and IFN-stimulated genes (ISGs) expression. Furthermore, we demonstrated that knockdown of D129L by specific small interfering RNAs enhanced the transcription of IFN- β mRNA in the ASFV-infected primary porcine alveolar macrophages (PAMs). Mechanistically, pD129L did not affect the expression of adaptors in the cGAS-STING signaling pathway or the nuclear translocation of IFN regulatory factor 3 (IRF3). Importantly, pD129L specifically bound to the transcriptional coactivators CBP/p300 in the nucleus and inhibited the interaction of IRF3 with CBP/p300, which in turn suppressed the activation of the IFN-β promoter to antagonize the IFN- β induction. More specifically, the HrcA domain of pD129L and the IRF3-binding domain of p300 were mapped crucial for their interaction. Taken together, our findings demonstrate a novel immunoevasion mechanism evolved by ASFV to escape the host antiviral response, which provides a new target for the development of antiviral strategies. IMPORTANCE African swine fever (ASF) is an acute, hemorrhagic, and severe porcine infectious disease caused by African swine fever virus (ASFV). ASF outbreaks severely threaten the global pig industries and result in serious economic losses. No safe and efficacious commercial vaccine is currently available except in Vietnam. To date, large gaps in the knowledge concerning viral biological characteristics and immunoevasion strategies have hindered the ASF vaccine design. In this study, we demonstrate that pD129L negatively regulates the type I interferon (IFN) signaling pathway by interfering with the interaction of the transcriptional coactivator p300 and IRF3, thereby inhibiting the induction of type I IFNs. This study reveals a novel immunoevasion strategy employed by ASFV, shedding new light on the intricate mechanisms for ASFV to evade the host immune responses.

African swine fever virus early protein pI73R suppresses the type-I IFN promoter activities

I226R Protein of African Swine Fever Virus Is a Suppressor of Innate Antiviral Responses

African swine fever virus pA104R protein acts as a suppressor of type I interferon signaling

African swine fever virus S273R protein antagonizes type I interferon production by interfering with TBK1 and IRF3 interaction

African swine fever virus I73R is a critical virulence-related gene: A potential target for attenuation

African swine fever virus MGF360-4L protein attenuates type I interferon response by suppressing the phosphorylation of IRF3

African swine fever virus QP383R dampens type I interferon production by promoting cGAS palmitoylation

African swine fever virus M1249L protein antagonizes type I interferon production via suppressing phosphorylation of TBK1 and degrading IRF3

African Swine Fever Virus MGF360-14L Negatively Regulates Type I Interferon Signaling by Targeting IRF3

African swine fever virus MGF360-11L negatively regulates cGAS-STING-mediated inhibition of type I interferon production

The D129L protein of African swine fever virus interferes with the binding of transcriptional coactivator p300 and IRF3 to prevent beta interferon induction

pK205R targets the proximal element of IFN-I signaling pathway to assist African swine fever virus to escape host innate immunity at the early stage of infection

African Swine Fever Virus pF778R Attenuates Type I Interferon Response by Impeding STAT1 Nuclear Translocation

African swine fever virus structural protein p17 inhibits IRF3 activation by recruiting host protein PR65A and inducing apoptotic degradation of STING

African Swine Fever Virus MGF360-12L Inhibits Type I Interferon Production by Blocking the Interaction of Importin α and NF-κB Signaling Pathway

pMGF505-7R determines pathogenicity of African swine fever virus infection by inhibiting IL-1β and type I IFN production

The African Swine Fever Virus Virulence Determinant DP96R Suppresses Type I IFN Production Targeting IRF3

African swine fever virus MGF505–6R attenuates type I interferon production by targeting STING for degradation

African swine fever virus I267L acts as an important virulence factor by inhibiting RNA polymerase III-RIG-I-mediated innate immunity

ASFV pA151R negatively regulates type I IFN production via degrading E3 ligase TRAF6

Structural Insight into African Swine Fever Virus I73R Protein Reveals It As a Z-DNA Binding Protein